Dupilumab in Eosinophilic Gastritis

NCT03678545 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Eosinophilic Gastritis
Eosinophilic Gastroenteritis

Interventions

DRUG: Dupilumab (blinded)
DRUG: Placebo (blinded)

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]
[object Object]